Latigo Biotherapeutics, Inc. (NASDAQ:LTGO) IPO
IPO
Priced at US$18.00 a share on Aug 6, 2026.
- Price
- US$18.00 a share
- Shares offered
- 19,200,000 shares of common stock
- Offering size
- US$345.6 million
- Underwriters' option
- Up to 2,880,000 more shares
- Listing
- LTGO on the Nasdaq Global Select Market
- Underwriters
- Goldman Sachs & Co. LLC, Jefferies, Leerink Partners, Guggenheim Securities · In the order on the cover
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Mar 27, 2026 |
| Filed publicly | Jul 17, 2026 |
| Amended twice | Newest Aug 4, 2026 |
| Shares registered with an exchange | Aug 4, 2026 |
| Declared effective by the SEC | Aug 6, 2026 |
| Final prospectus, with the price | Aug 7, 2026 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Aug 7, 2026 |
| EFFECT · Notice that a registration is effective | Aug 6, 2026 |
| S-1MEF · Registration of more shares for the same offering | Aug 6, 2026 |
| CERT · Exchange's certificate of listing | Aug 6, 2026 |
| 8-A12B · Registration of shares for listing on an exchange | Aug 4, 2026 |
| S-1/A · Registration statement, amended | Aug 4, 2026 |
| S-1/A · Registration statement, amended | Aug 3, 2026 |
| S-1 · Registration statement | Jul 17, 2026 |
| DRS/A · Draft registration statement, amended | Jun 5, 2026 |
| DRS/A · Draft registration statement, amended | May 18, 2026 |
| DRS · Draft registration statement | Mar 27, 2026 |
From the cover of the final prospectus (424B4) filed Aug 7, 2026